ClinVar Miner

Submissions for variant NM_000243.3(MEFV):c.2040G>C (p.Met680Ile)

dbSNP: rs28940580
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 37
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000030179 SCV000052839 pathogenic Familial Mediterranean fever 2011-08-18 criteria provided, single submitter curation Converted during submission to Pathogenic.
Eurofins Ntd Llc (ga) RCV000222364 SCV000224797 pathogenic not provided 2014-10-14 criteria provided, single submitter clinical testing
GeneDx RCV000222364 SCV000279057 pathogenic not provided 2022-09-06 criteria provided, single submitter clinical testing Accounts for approximately 9% of identifiable pathogenic MEFV variants in patients of different ethnic groups (Aksentijevich et al., 1999); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 20483145, 27621632, 19967574, 10447272, 16179998, 24433404, 16785446, 30513227, 27457448, 29080837, 19302049, 33440462, 10852276, 20669279, 23973724, 20437121, 21623663, 9288758, 19863562, 24141617, 10364520, 10090880, 23907647, 27513391, 12908875, 19151977, 26510601, 28492532, 29543225, 30783801, 32199921, 34426522, 31589614, 11977178, 32441320, 10662876)
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000222364 SCV000604173 pathogenic not provided 2022-09-14 criteria provided, single submitter clinical testing The MEFV c.2040G>C; p.Met680Ile variant (rs28940580) has been published as a common familial Mediterranean fever pathogenic variant (Moradian 2014, The International FMF Consortium 1997). This variant is also reported as pathogenic by multiple laboratories in ClinVar (Variation ID: 36507). It is found in the general population with an overall allele frequency of 0.01% (26/251474 alleles) in the Genome Aggregation Database. Based on available information, this variant is considered to be pathogenic. References: Moradian MM et al. Patient management and the association of less common familial Mediterranean fever symptoms with other disorders. Genet Med. 2014; 16(3):258-63. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997; 90:797-807.
Fulgent Genetics, Fulgent Genetics RCV002477026 SCV000611205 pathogenic Familial Mediterranean fever; Familial Mediterranean fever, autosomal dominant; Acute febrile neutrophilic dermatosis 2022-04-08 criteria provided, single submitter clinical testing
Invitae RCV000030179 SCV000629033 pathogenic Familial Mediterranean fever 2024-01-22 criteria provided, single submitter clinical testing This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 680 of the MEFV protein (p.Met680Ile). This variant is present in population databases (rs28940580, gnomAD 0.02%). This missense change has been observed in individual(s) with symptoms of familial Mediterranean fever (PMID: 9288758, 21623663, 23907647, 23973724). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 36507). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. For these reasons, this variant has been classified as Pathogenic.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000222364 SCV001134279 pathogenic not provided 2019-02-20 criteria provided, single submitter clinical testing The best available variant frequency is uninformative. Found in at least one symptomatic patient. Predicted to have a tolerated effect on the protein. One other pathogenic or likely pathogenic variant affects the same amino acid. Occurs in multiple cases with a recessive pathogenic variant in the same gene. Assessment of experimental evidence suggests this variant results in abnormal protein function.
CeGaT Center for Human Genetics Tuebingen RCV000222364 SCV001245671 pathogenic not provided 2024-03-01 criteria provided, single submitter clinical testing MEFV: PM3:Very Strong, PS1, PM5, PM2:Supporting, PS3:Supporting, BP4
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001197705 SCV001368484 pathogenic Acute febrile neutrophilic dermatosis 2020-02-25 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM1,PM3,PM5.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000222364 SCV001447340 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Clinical Genetics and Genomics, Karolinska University Hospital RCV000222364 SCV001449578 pathogenic not provided 2014-10-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000030179 SCV001810498 pathogenic Familial Mediterranean fever 2021-07-22 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000222364 SCV002024334 pathogenic not provided 2020-10-16 criteria provided, single submitter clinical testing
Centogene AG - the Rare Disease Company RCV000030179 SCV002059616 pathogenic Familial Mediterranean fever 2021-08-12 criteria provided, single submitter clinical testing
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002251932 SCV002523125 pathogenic See cases 2021-04-06 criteria provided, single submitter clinical testing ACMG classification criteria: PS3, PS4, PM2, PM3, BP4
Department of Human Genetics, Hannover Medical School RCV002254152 SCV002525496 pathogenic Familial Mediterranean fever, autosomal dominant 2022-06-09 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002262586 SCV002543729 pathogenic Autoinflammatory syndrome 2022-02-08 criteria provided, single submitter clinical testing
Laboratory of Medical Genetics, National & Kapodistrian University of Athens RCV000030179 SCV002577425 pathogenic Familial Mediterranean fever 2022-07-18 criteria provided, single submitter clinical testing PS1, PS3, PM1, PM5, PM2, PP5, BP4
MGZ Medical Genetics Center RCV000030179 SCV002580913 pathogenic Familial Mediterranean fever 2022-06-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV002415433 SCV002723049 pathogenic Inborn genetic diseases 2018-01-11 criteria provided, single submitter clinical testing The p.M680I pathogenic mutation (also known as c.2040G>C), located in coding exon 10 of the MEFV gene, results from a G to C substitution at nucleotide position 2040. The methionine at codon 680 is replaced by isoleucine, an amino acid with highly similar properties. This mutation is well documented as one of the five most common MEFV mutations and has been seen in both the homozygous and heterozygous states in multiple individuals with a clinical diagnosis of familial Mediterranean fever (FMF). In addition, codon 680 in the MEFV gene has been documented as a mutational hotspot and is associated with severe manifestations of FMF (Neocleous V et al. Ann. Hum. Genet., 2015 Jan;79:20-7; Touitou I. Eur. J. Hum. Genet., 2001 Jul;9:473-83; The International FMF Consortium. Cell, 1997 Aug;90:797-807). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
Al Jalila Children's Genomics Center, Al Jalila Childrens Speciality Hospital RCV000222364 SCV002818117 pathogenic not provided 2022-12-17 criteria provided, single submitter clinical testing
Intergen, Intergen Genetics and Rare Diseases Diagnosis Center RCV000030179 SCV004013446 pathogenic Familial Mediterranean fever 2023-07-18 criteria provided, single submitter clinical testing
Baylor Genetics RCV002254152 SCV004194411 pathogenic Familial Mediterranean fever, autosomal dominant 2023-10-16 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000222364 SCV004226903 pathogenic not provided 2022-06-14 criteria provided, single submitter clinical testing PM1, PS3, PS4
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000030179 SCV004847543 pathogenic Familial Mediterranean fever 2022-11-03 criteria provided, single submitter clinical testing The p.Met680Ile variant in MEFV has been reported in the homozygous and compound heterozygous state in numerous individuals with familial Mediterranean fever and accounts for approximately 9% of pathogenic MEFV variants in individuals of different ethnic groups (example: Aksentijevich 1999 PMID: 10090880). It has been reported in ClinVar (Variation ID 36507) and has been identified in 6/68036 European chromosomes by gnomAD ((http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive familial Mediterranean fever. ACMG/AMP Criteria applied: PM2_Supporting, PM3_VeryStrong, PP1_Strong.
OMIM RCV000030179 SCV000022808 pathogenic Familial Mediterranean fever 1999-04-01 no assertion criteria provided literature only
GeneReviews RCV000030179 SCV000484965 not provided Familial Mediterranean fever no assertion provided literature only
Counsyl RCV000030179 SCV001132428 pathogenic Familial Mediterranean fever 2019-03-15 no assertion criteria provided clinical testing
Al Jalila Children's Genomics Center, Al Jalila Childrens Speciality Hospital RCV000515335 SCV001448269 pathogenic Familial Mediterranean fever; Familial Mediterranean fever, autosomal dominant 2020-10-04 flagged submission clinical testing
Natera, Inc. RCV000030179 SCV001462099 pathogenic Familial Mediterranean fever 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000222364 SCV001741393 pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000222364 SCV001807652 pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000222364 SCV001930242 pathogenic not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000222364 SCV001959280 pathogenic not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000222364 SCV001973052 pathogenic not provided no assertion criteria provided clinical testing
Clinic of Clinical Immunology with Stem Cell Bank, Expert Centre for Rare Diseases - PID, University Hospital "Alexandrovska" RCV000030179 SCV002573424 pathogenic Familial Mediterranean fever 2022-05-01 no assertion criteria provided clinical testing
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas RCV000030179 SCV004101055 pathogenic Familial Mediterranean fever 2023-11-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.